In addition, Rezvani et al. demonstrated that the WT1-specific CD8 + T cells of patients with chronic myelogenous leukemia or AML targeted more WT1-epitopes than healthy volunteers [34]. This evidence concerns the gene WT1 and chronic myelogenous leukemia, BCR-ABL1 positive.